Agios Pharmaceuticals Inc...

NASDAQ: AGIO · Real-Time Price · USD
37.00
0.32 (0.87%)
At close: Aug 15, 2025, 3:59 PM
37.14
0.38%
After-hours: Aug 15, 2025, 07:37 PM EDT

Agios Pharmaceuticals Income Statement

Financials in USD. Fiscal year is January - December.
Fiscal Year FY 2024 FY 2023 FY 2022 FY 2021
Period Ending Dec 31, 2024 Dec 31, 2023 Dec 31, 2022 Dec 31, 2021
Revenue
36.5M 26.82M 14.24M n/a
Cost of Revenue
4.17M 9.5M 1.7M 18.78M
Gross Profit
32.33M 17.32M 12.54M -18.78M
Operating Income
-425.74M -391.49M -389.05M -378.42M
Interest Income
48.08M 33.34M 12.79M 836K
Pretax Income
717.97M -352.09M -231.8M -356.51M
Net Income
673.73M -352.09M -74.56M 1.6B
Selling & General & Admin
156.78M 119.9M 121.67M 121.44M
Research & Development
301.29M 288.9M 279.91M 256.97M
Other Expenses
n/a n/a n/a 14.43M
Operating Expenses
458.07M 408.81M 401.58M 378.42M
Interest Expense
n/a n/a n/a n/a
Selling & Marketing Expenses
n/a n/a n/a n/a
Cost & Expenses
462.24M 418.31M 403.29M 378.42M
Income Tax Expense
44.24M n/a -157.25M n/a
Shares Outstanding (Basic)
56.81M 55.65M 54.79M 60.45M
Shares Outstanding (Diluted)
57.89M 55.65M 54.79M 60.45M
EPS (Basic)
11.86 -6.33 -1.36 26.55
EPS (Diluted)
11.64 -6.33 -1.36 26.55
EBITDA
-425.74M -384.86M -380.48M -337.73M
EBIT
-425.74M -391.49M -389.05M -356.51M
Depreciation & Amortization
5.65M 6.62M 18.56M 18.78M